“…23 Other work indicates that plasma bradykinin levels are significantly higher in CRPS patients than in healthy controls. 24 It has also been observed that corticosteroids significantly diminished the clinical features of CRPS, indicating that inflammatory mechanisms might evolve into CRPS. 25 Furthermore, several small clinical studies demonstrated that, compared with controls and non-CRPS pain patients, CRPS patients display significant increases in proinflammatory cytokines, including interleukin (IL)-1b, IL-6, and tumour necrosis factor a (TNFa), and a decrease in antiinflammatory factors, including IL-10 cytokines in local blister fluid, circulating plasma, and cerebrospinal fluid.…”